MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

Astrana Health Inc

Gesloten

SectorGezondheidszorg

28.08 0.36

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

27.75

Max

28.89

Belangrijke statistieken

By Trading Economics

Inkomsten

-9.8M

373K

Verkoop

301M

956M

K/W

Sectorgemiddelde

130.476

87.826

Winstmarge

0.039

Werknemers

1,900

EBITDA

7.9M

39M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+11.78% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-148M

1.4B

Vorige openingsprijs

27.72

Vorige sluitingsprijs

28.08

Nieuwssentiment

By Acuity

34%

66%

106 / 372 Rangschikking in Healthcare

Astrana Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

7 jan 2026, 23:11 UTC

Winsten

Samsung Electronics Expects Record Fourth-Quarter Profit Beat

7 jan 2026, 22:55 UTC

Belangrijke Marktbewegers

Defense Stocks Rebound After Trump Says He Wants $1.5 Trillion Military Budget in 2027

7 jan 2026, 21:39 UTC

Belangrijke Marktbewegers

Raytheon Down Following Trump Post Criticizing Company

7 jan 2026, 20:13 UTC

Belangrijke Marktbewegers

AbbVie, Revolution Medicines Stocks Gain on Report of Possible Acquisition

7 jan 2026, 20:03 UTC

Belangrijke Marktbewegers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Executive Pay

7 jan 2026, 23:46 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

7 jan 2026, 23:46 UTC

Marktinformatie

Nikkei May Decline as China-Japan Tensions Linger -- Market Talk

7 jan 2026, 23:42 UTC

Acquisities, Fusies, Overnames

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 5th Update

7 jan 2026, 23:34 UTC

Marktinformatie

Gold Edges Higher Amid Lingering Geopolitical Risks -- Market Talk

7 jan 2026, 23:29 UTC

Acquisities, Fusies, Overnames

Constellation Closes Deal for Calpine, Creating Biggest Electricity Generator -- Barrons.com

7 jan 2026, 22:48 UTC

Marktinformatie

Infratil's Discount to Net Asset Value Too Good to Ignore -- Market Talk

7 jan 2026, 22:46 UTC

Winsten

Samsung Electronics Estimates 2025 Rev KRW332.770T Vs KRW300.870T >005930.SE

7 jan 2026, 22:45 UTC

Winsten

Samsung Electronics Estimates 2025 Oper Pft KRW43.530T Vs KRW32.730T >005930.SE

7 jan 2026, 22:43 UTC

Acquisities, Fusies, Overnames

Revolution Medicines Draws Takeover Interest -- 2nd Update

7 jan 2026, 22:42 UTC

Winsten

Samsung Electronics 4Q Oper Pft Estimate Beat FactSet-Compiled Consensus Forecast

7 jan 2026, 22:41 UTC

Winsten

Samsung Electronics Sees 4Q Oper Pft KRW20.000T Vs KRW6.490T >005930.SE

7 jan 2026, 22:41 UTC

Winsten

Samsung Electronics Sees 4Q Rev KRW93.000T Vs KRW75.790T >005930.SE

7 jan 2026, 22:40 UTC

Belangrijke Marktbewegers

Defense Stocks Rebound After Trump Says He Wants $1.5T Military Budget in 2027

7 jan 2026, 22:31 UTC

Marktinformatie

Macro Tailwinds Strengthen for Chalice Mining -- Market Talk

7 jan 2026, 22:22 UTC

Marktinformatie

Northern Star's Run of Disruptions Increasingly a Concern -- Market Talk

7 jan 2026, 22:01 UTC

Marktinformatie

Valuations of New Zealand Property Stocks Supportive -- Market Talk

7 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

7 jan 2026, 21:46 UTC

Marktinformatie

Northern Star's Revised Guidance Looks Achievable -- Market Talk

7 jan 2026, 21:22 UTC

Acquisities, Fusies, Overnames

Eli Lilly to Buy Ventyx Biosciences for $14 a Share >LLY VTYX

7 jan 2026, 21:18 UTC

Acquisities, Fusies, Overnames

Lilly To Acquire Ventyx Biosciences To Advance Oral Therapies Targeting Inflammatory-mediated Diseases >LLY VTYX

7 jan 2026, 21:05 UTC

Acquisities, Fusies, Overnames

Warner Discovery Rejects Paramount's Amended Hostile Bid -- 4th Update

7 jan 2026, 20:29 UTC

Acquisities, Fusies, Overnames

AbbVie Near Deal for Revolution Medicines -- Update

7 jan 2026, 20:27 UTC

Marktinformatie

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

7 jan 2026, 19:58 UTC

Marktinformatie

Oil Falls As U.S. to Receive Sanctioned Venezuelan Crude -- Market Talk

7 jan 2026, 19:48 UTC

Belangrijke Marktbewegers

Defense Contractor Shares Fall on Trump's Push to Ban Industry Dividends, Buybacks, Limit Exec Pay

Peer Vergelijking

Prijswijziging

Astrana Health Inc Prognose

Koersdoel

By TipRanks

11.78% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 31.5 USD  11.78%

Hoogste 37 USD

Laagste 26 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Astrana Health Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

6

Buy

2

Hold

0

Sell

Sentiment

By Acuity

106 / 372 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Astrana Health Inc

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
help-icon Live chat